{"id":"W2084452268","doi":"10.1182/blood-2003-09-3032","title":"Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Imatinib mesylate; Imatinib; Nausea; Pharmacokinetics; Internal medicine; Gastroenterology; Vomiting; Myeloid leukemia; Philadelphia chromosome; Chromosomal translocation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001144925,0.0005134245,0.001084429,0.0002122934,0.0001779116,0.0003059148,0.0003327984,0.0004399259,0.001170649],"category_scores_gemma":[0.000769444,0.0001360496,0.0004658596,0.0003389602,0.0002941523,0.0002890793,0.0001454246,0.00093799,0.0002033193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005553389,"about_ca_system_score_gemma":0.000893739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008703977,"about_ca_topic_score_gemma":0.002339297,"domain_scores_codex":[0.999711,0.0001455257,0.0000229228,0.00003774695,0.00005101491,0.00003186449],"domain_scores_gemma":[0.9993181,0.0002172253,0.0001821537,0.00003057171,0.0000493798,0.0002025657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1519911,0.01836,0.09665046,0.002469391,0.00310192,0.001427219,0.0006332648,0.006462175,0.1480886,0.0004903124,0.01210114,0.5582245],"study_design_scores_gemma":[0.1636993,0.4254925,0.3334954,0.0003350322,0.003194873,0.005941718,0.0001928324,0.002951192,0.03115497,0.0002929854,0.033159,0.00009022772],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871623,0.009913609,0.0003670912,0.0002951115,0.00002790272,0.0003081696,0.0009430132,0.00003345345,0.0009493101],"genre_scores_gemma":[0.9744193,0.0154249,0.002753902,0.0008116587,0.0001091176,0.0008050666,0.004622216,0.00003392794,0.00101984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001170649,"threshold_uncertainty_score":0.006055057,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01754745499324663,"score_gpt":0.2983391117999296,"score_spread":0.280791656806683,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}